- 基本信息
导师姓名:
|
黄雷
|
学科代码:
|
100100
|
|
性别:
|
女
|
学科名称:
|
基础医学
|
培养单位:
|
基础医学院
|
三级学科
|
|
导师类型:
|
博士生导师
|
专业领域名称:
|
|
联系方式:
|
上海交通大学医学院组织胚胎学与遗传发育系
上海市重庆南路280号5号楼505 室 200025
电话:021-63846590-776576
|
专业领域代码:
|
|
邮编:
|
200025
|
邮箱地址:
|
leihuang@shsmu.edu.cn
|
- 研究方向 (点击浏览详细信息)
- 社会任职
|
上海病理生理学会理事
|
黄浦区人大代表
|
上海交通大学医学院“中青年知识分子联谊会”副会长
|
美国人类遗传学会会员、中国遗传学会会员、中国细胞生物学学会会员
|
- 科研项目
82073111 | 黏蛋白1泛素化修饰的动态调控机制及其肿瘤治疗意义研究 | 国家自然科学基金面上项目 |
2021-01~2024-12
|
55万元
| 课题负责人 |
81874197 | 黏蛋白1调控肿瘤干细胞分裂模式的机制及临床意义研究 | 国家自然科学基金面上项目 |
2019-01~2022-12
|
57万元
| 课题负责人 |
2015CB910403 | 代谢应激过程中蛋白质修饰相关的生物标志物和潜在靶点的发现 | 国家重大研究计划项目 |
2015-01~2019-12
|
60万元
| 课题参与人 |
81472461 | MUC1在产后乳腺退化中的作用及其与TNBC发病的关系研究 | 国家自然科学基金面上项目 |
2015-01~2018-12
|
72万元
| 课题负责人 |
81272262 | MUC1在肺癌早期发生和转移中的作用和机制研究 | 国家自然科学基金面上项目 |
2013-01~2016-12
|
80万元
| 课题负责人 |
2012CB967000 | 肿瘤干细胞的动态演进及干预研究 | 国家重大研究计划项目 |
2012-01~2016-12
|
92万元
| 课题参与人 |
11140902600 | 乳腺癌小鼠模型的建立及肿瘤发生机制研究 | 上海市科委实验动物研究项目 |
2011-12~2013-09
|
20万元
| 课题负责人 |
81071666 | MDMX基因定点诱变小鼠模型的建立及其生物学功能研究 | 国家自然科学基金面上项目 |
2011-01~2013-12
|
35万元
| 课题负责人 |
NCET-08-0349 | MUC1在肺癌治疗中的作用及其机制研究 | 教育部“新世纪优秀人才支持计划 |
2009-01~2011-12
|
50万元
| 课题负责人 |
30871363 | MUC1在乳腺癌治疗中的作用及其机制研究 | 国家自然科学基金面上项目 |
2009-01~2011-12
|
35万元
| 课题负责人 |
07pj14065 | MUC1在肺癌发病和治疗中的作用及其机制研究 | 上海市科委“浦江人才计划” |
2007-09~2009-09
|
20万元
| 课题负责人 |
30671169 | MUC1过度表达小鼠模型的建立及其致瘤机制研究 | 国家自然科学基金面上项目 |
2007-01~2009-12
|
30万元
| 课题负责人 |
- 学术论文
Morimoto Y, Fushimi A, Yamashita N, Hagiwara M, Bhattacharya A, Cheng J, Frost TC, Ahmad R, Daimon T,, Hata T, Takahashi H, Yamamoto M, Suzuki Y, DeCaprio JA, Kufe D*.
|
Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment
|
Oncogene
|
2022
|
41(27):3511-3523
|
Li Q, Chu Y, Li S, Yu L, Deng H, Liao C, Liao X, Yang C, Qi M, Cheng J, Chen G,
|
The oncoprotein MUC1 facilitates breast cancer progression by promoting Pink1-dependent mitophagy via ATAD3A destabilization.
|
Cell Death & Disease.
|
2022
|
13(10): 899-915
|
Pang Z#,Dong X#,Deng H#,Wang C,Liao X,Liao C,Liao Y,Tian W,Cheng Jinke,Chen G,Yi H*,
|
MUC1 triggers lineage plasticity of Her2 positive mammary tumors
|
Oncogene
|
2022
|
41(22):3064-3078
|
Liao C, Yu L, Pang Z, Deng H, Liao X, Li S, Cheng J, Qi M*, Chen G*,
|
WWP1 targeting MUC1 for ubiquitin-mediated lysosomal degradation to suppress carcinogenesis
|
Signal Transduction and Targeted Therapy
|
2021
|
6(1):297-300
|
Guan Y,Wang Y,Li B,Shen K,Li Q,Ni Y*,
|
Mitophagy in carcinogenesis, drug resistance and anticancer therapeutics.
|
Cancer Cell International.
|
2021
|
21(350):1-9
|
Wu AY, Gu LY, Cang W, Cheng MX, Wang WJ, Di W,, Qiu LH*.
|
Fn14 overcomes cisplatin resistance of high-grade serous ovarian cancer by promoting Mdm2-mediated p53-R248Q ubiquitination and degradation.
|
J Exp Clin Cancer Res.
|
2019
|
38 (1):176.
|
Lv Y, Cang W, Li Q, Liao X, Zhan M, Deng H, Li S, Jin W, Pang Z, Qiu X, Zhao K, Chen G, Qiu L*,
|
Erlotinib overcomes paclitaxel-resistant cancer stem cells by blocking the EGFR-CREB/GRβ-IL-6 axis in MUC1-positive cervical cancer
|
Oncogenesis
|
2019
|
8(12):70
|
Wang Y, Liao X, Ye Q*,
|
Clinic implication of MUC1 O-glycosylation and C1GALT1 in esophagus squamous cell carcinoma.
|
Sci China Life Sci.
|
2018
|
61(11):1389-1395.
|
Gamze Kuser-Abali, Lu Gong, Jiawei Yan, Qingqing Liu, Weiqi Zeng, Amanda Williamson, Chuan Bian Lim, Mary Ellen Molloy, John B. Little,, Zhi-Min Yuan.
|
An EZH2-mediated epigenetic mechanism behind p53-dependent tissue sensitivity to DNA damage.
|
Proc Natl Acad Sci U S A.
|
2018
|
115(13):3452-3457.
|
Yuan Li, Zhi Pang, Xinran Dong, Xiaodong Liao, Huayun Deng, Chunhua Liao, Yahui Liao, Guoqiang Chen,
|
MUC1 induces M2 type macrophage influx during postpartum mammary gland involution and triggers breast cancer.
|
Oncotarget.
|
2018
|
9 (3): 3446-3458
|
Hu Y, Li D, Wu A, Qiu X, Di W,, Qiu L*.
|
TWEAK-stimulated macrophages inhibit metastasis of epithelial ovarian cancer via exosomal shuttling of microRNA.
|
Cancer Lett.
|
2017
|
393:60-67.
|
Fu RJ, He W, Wang XB, Li L, Zhao HB, Liu XY, Pang Z, Chen GQ,, Zhao KW*.
|
DNMT1-mediated hypermethylation of Krüppel-like factor 5 regulates the progression of clear cell renal cell carcinoma.
|
Cell Death & Disease
|
2017
|
8(7):e2952.
|
Jin W, Liao X, Lv Y, Pang Z, Wang Y, Li Q, Liao Y, Ye Q, Chen G, Zhao K*,
|
MUC1 induces acquired chemoresistance by upregulating ABCB1 in EGFR-dependent manner.
|
Cell Death & Disease
|
2017
|
8(8):e2980
|
Zhao XY, Li L, Wang XB, Fu RJ, Lv YP, Jin W, Meng C, Chen GQ,, Zhao KW*.
|
Inhibition of Snail Family Transcriptional Repressor 2 (SNAI2) Enhances Multidrug Resistance of Hepatocellular Carcinoma Cells.
|
PLoS ONE.
|
2016
|
11(10):e0164752.
|
Wang Y, Shang W, Lei X, Shen S, Zhang H, Wang Z,, Yu Z, Ong H, Yin X, Yang W, Zhang C.
|
Opposing functions of PLAG1 in pleomorphic adenoma: a microarray analysis of PLAG1 transgenic mice
|
Biotechnol Lett
|
2013
|
35(9):1377-85
|
Wang F, Wang PX, Wu XL, Dang SY, Chen Y, Ni YY, Gao LH, Lu SY, Kuang Y,, Fei J, Wang ZG, Pang XF.
|
Deficiency of Adiponectin Protects against Ovariectomy-Induced Osteoporosis in Mice.
|
PLoS One
|
2013
|
8(7):e68497.
|
Xu WY, Gu MM, Sun LH, Guo WT, Zhu HB, Ma JF, Yuan WT, Kuang Y, Ji BJ, Wu XL, Chen Y, Zhang HX, Sun FT, Huang W,, Chen SD, Wang ZG.
|
A nonsense mutation in DHTKD1 causes Charcot-Marie-Tooth disease type 2 in a large Chinese pedigree.
|
Am J Hum Genet
|
2012
|
91(6):1088-94.
|
Li Y, Yi H, Yao Y, Liao X, Xie Y, Yang J, Yan Z, Wang L, Lu S, Kuang Y, Gu M, Fei J, Wang Z,
|
The Cytoplasmic Domain of MUC1 Induces Hyperplasia in the Mammary Gland and Correlates with Nuclear Accumulation of β-catenin.
|
PLoS ONE
|
2011
|
6(4):e19102
|
Shen S, Yang W, Wang Z, Lei X, Xu L, Wang Y, Wang L,, Yu Z, Zhang X Li J, Chen Y, Zhao X, Yin X, Zhang C.
|
. Tumor-Initiating Cells Are Enriched in CD44(hi) Population in Murine Salivary Gland Tumor.
|
PLoS ONE.
|
2011
|
6(8)
|
Ye Q, Yan Z, Liao X, Li Y, Yang J, Sun J, Kawano T, Wang X, Cao Z,Wang Z,
|
MUC1 induces metastasis in esophageal squamous cell carcinoma by upregulating matrix metalloproteinase 13
|
Lab Invest
|
2011
|
91(5):778-87
|
, Yan Z, Liao X, Li Y, Yang J, Wang ZG, Zuo Y, Kawai H, Shadfan M, Ganapathy S, Yuan ZM.
|
The MDM2/MDMX complex is required for control of p53 activity in vivo.
|
Proc Natl Acad Sci U S A.
|
2011
|
108(29):12001-6
|
Shen S, Yang W, Wang Z, Lei X, Xu L, Wang Y, Wang L,, Yu Z, Zhang X Li J, Chen Y, Zhao X, Yin X, Zhang C.
|
. Tumor-Initiating Cells Are Enriched in CD44(hi) Population in Murine Salivary Gland Tumor.
|
PLoS ONE.
|
2011
|
6(8)
|
, Liao X., Beckett M., Li Y., Khanna K. K., Wang Z., Kharbanda S., Weichselbaum R. and Kufe D.
|
MUC1 Oncoprotein Interacts Directly With ATM and Promotes the DNA Damage Response to Ionizing Radiation.
|
Genes & Cancer.
|
2010
|
1(3):239-250
|
Macdermed DM, Khodarev NN, Pitroda SP, Edwards DC, Pelizzari CA,, Kufe DW, Weichselbaum RR.
|
MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients.
|
BMC Med Genomics.
|
2010
|
3(1):16.1-12
|
Khodarev NN, Pitroda SP, Beckett MA, Macdermed DM,, Kufe DW, Weichselbaum RR.
|
MUC1-Induced Transcriptional Programs Associated with Tumorigenesis Predict Outcome in Breast and Lung.
|
Cancer Res.
|
2009
|
69(7):2833-7
|
Wu XL, Gu MM,, Liu XS, Zhang HX, Ding XY, Xu JQ, Cui B, Wang L, Lu SY, Chen XY, Zhang HG, Huang W, Yuan WT, Yang JM, Gu Q, Fei J, Chen Z, Yuan ZM, Wang ZG.
|
Multiple synostoses syndrome is due to a missense mutation in exon 2 of FGF9 gene.
|
Am J Hum Genet.
|
2009
|
85(1):53-63.
|
Leng Y, Cao C, Ren J,, Chen D, Kufe D.
|
Nuclear import of the MUC1-C oncoprotein is mediated by nucleoporin Nup62.
|
J Biol Chem.
|
2007
|
282(27):19321-30
|
Ren J, Raina D, Chen W, Li G,, Kufe D.
|
MUC1 oncoprotein functions in activation of fibroblast growth factor receptor signaling.
|
Mol Cancer Res.
|
2006
|
4(11):873-83.
|
, Chen D., Liu D, Yin L, Kharbanda S, Kufe D.
|
MUC1 Oncoprotein Blocks Glycogen Synthasa Kinase 3β-Mediated Phosphorylation and Degradation of β-catenin.
|
Cancer Research.
|
2005
|
65(22) :10413-10422
|
Ren J, Agata N, Chen D, Li Y, Yu WH,, Raina D, Chen W, Kharbanda S, Kufe D.
|
Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents.
|
Cancer Cell.
|
2004
|
5(2):163-75.
|
Yin L,, Kufe D.
|
MUC1 oncoprotein activates the FOXO3a transcription factor in a survival response to oxidative stress.
|
J Biol Chem.
|
2004
|
279(44):45721-7
|
, Ren J, Chen D, Li Y, Kharbanda S, Kufe D.
|
MUC1 Cytoplasmic Domain Coactivates Wnt Target Gene Transcription and Confers Transformation.
|
Cancer Biol Ther.
|
2003
|
2(6):702-706.
|
|